Dual-target mu opioid-dopamine D3 receptor (MOR-D3R) ligands based on etonitazene: New leads for transforming "nitazenes" into novel analgesics. - Jahan K; Glatfelter G; Sanchez J; Maitland AD; Bonifazi A; Saab E; Keegan BM; Rais R; Bi GH; Gomez JL; Michaelides M; Xi ZX; et al. (European journal of medicinal chemistry, 2026)